Literature DB >> 26582738

Systematic review of case reports on the abscopal effect.

Yazan Abuodeh, Puja Venkat, Sungjune Kim.   

Abstract

Radiation therapy is a highly effective local treatment for cancer. However, sporadic events of tumor regression in unirradiated fields, known as abscopal effect, have been observed for decades. This abscopal effect has more recently been postulated to be a result of antitumor immune response induced by radiation therapy. With the advent of modern immunotherapy, the potential for immune activation by radiation therapy defines a novel role for radiation therapy in systemic disease. In this context, we have searched documented cases abscopal effect of radiation therapy in literature. A total of 46 reported cases have been identified from 1969 to 2014 with median radiation dose of 31 Gy, median follow-up of 17.5 months, and median documented time to notice the abscopal effect was 2 months. This review systematically summarizes all clinical case reports of abscopal effect to gain insight into this uncommon but important phenomenon.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26582738     DOI: 10.1016/j.currproblcancer.2015.10.001

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  134 in total

1.  Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab.

Authors:  Tijana Skrepnik; Srinath Sundararajan; Haiyan Cui; Baldassarre Stea
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

2.  Harnessing radiation to improve immunotherapy: better with particles?

Authors:  Marco Durante; Silvia Formenti
Journal:  Br J Radiol       Date:  2019-07-22       Impact factor: 3.039

Review 3.  Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy.

Authors:  M Protopapa; V Kouloulias; A Kougioumtzopoulou; Z Liakouli; C Papadimitriou; A Zygogianni
Journal:  Clin Transl Oncol       Date:  2019-06-28       Impact factor: 3.405

4.  News Feature: Radiation redux.

Authors:  Elie Dolgin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

5.  Stage III non-small cell lung cancer: escalation matters, but how?

Authors:  Aparna Madhukeshwar Hegde; Paul Raymond Walker
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 6.  Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers.

Authors:  Claire Vanpouille-Box; Silvia C Formenti; Sandra Demaria
Journal:  Clin Cancer Res       Date:  2017-07-27       Impact factor: 12.531

7.  Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.

Authors:  Paolo A Ascierto; Sanjiv S Agarwala; Gennaro Ciliberto; Sandra Demaria; Reinhard Dummer; Connie P M Duong; Soldano Ferrone; Silvia C Formenti; Claus Garbe; Ruth Halaban; Samir Khleif; Jason J Luke; Lluis M Mir; Willem W Overwijk; Michael Postow; Igor Puzanov; Paul Sondel; Janis M Taube; Per Thor Straten; David F Stroncek; Jennifer A Wargo; Hassane Zarour; Magdalena Thurin
Journal:  J Transl Med       Date:  2017-11-16       Impact factor: 5.531

8.  Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.

Authors:  Gayathri Vijayakumar; Stephen McCroskery; Peter Palese
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

9.  Harnessing the Immunomodulatory Effects of Radiation in Urinary Bladder Cancer.

Authors:  Waseem Abbas; Vineeta Goel; Arun Verma; Vineet G Gupta; Ranga R Rao
Journal:  Cureus       Date:  2019-02-20

Review 10.  Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.

Authors:  Ravi B Patel; Claire C Baniel; Raghava N Sriramaneni; Kristin Bradley; Stephanie Markovina; Zachary S Morris
Journal:  Brachytherapy       Date:  2018-08-02       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.